These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21832868)

  • 41. Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation.
    Nieder AM; Simon MA; Kim SS; Manoharan M; Soloway MS
    Urology; 2006 Apr; 67(4):737-41. PubMed ID: 16618564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H; Shirahase T; Kihara Y; Arai Y
    Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
    Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
    Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
    Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
    J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?
    Territo A; Fontanet S; Meneghetti I; Gallioli A; Sanguedolce F; Rodriguez-Faba Ó; Gaya JM; Palou J; Huguet J; Breda A
    Actas Urol Esp (Engl Ed); 2023 May; 47(4):221-228. PubMed ID: 36379260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.
    Sharpe JR; Duffy G; Chin JL
    J Urol; 1993 Mar; 149(3):457-9; discussion 459-60. PubMed ID: 8437246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
    Yokogi H; Wada Y; Mizutani M; Igawa M; Ishibe T
    Br J Urol; 1996 May; 77(5):676-9. PubMed ID: 8689109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ.
    Studer UE; Casanova G; Kraft R; Zingg EJ
    J Urol; 1989 Oct; 142(4):975-7. PubMed ID: 2795755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pelvi-ureteric obstruction by granuloma of the bladder mucosa after bacillus Calmette-Guérin perfusion for upper tract transitional cell carcinoma.
    Benejam Gual JM; Garcia-Miralles Gravalos R; Blas Marin M; Gil Sanz MJ; Rioja Sanz LA
    BJU Int; 1999 Feb; 83(3):346-7. PubMed ID: 10233511
    [No Abstract]   [Full Text] [Related]  

  • 50. Results of conservative treatment of upper urinary tract transitional cell carcinoma.
    Fujimoto N; Sato H; Mizokami A; Inatomi H; Matsumoto T
    Int J Urol; 1999 Aug; 6(8):381-7. PubMed ID: 10466449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Carcinoma in situ of the urinary tract--in patients with positive cytologies of upper urinary tract samples].
    Kitamura Y; Kobayasi K; Suzuki K; Saito T; Komatsubara S; Watanabe M
    Nihon Hinyokika Gakkai Zasshi; 2002 Jul; 93(5):621-6. PubMed ID: 12174638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review.
    Casey RG; Catto JW; Cheng L; Cookson MS; Herr H; Shariat S; Witjes JA; Black PC
    Eur Urol; 2015 May; 67(5):876-88. PubMed ID: 25466937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Upper urinary tract tumors: endourological management and treatment].
    de Fata FR; González J; Angulo J
    Arch Esp Urol; 2011 Apr; 64(3):279-88. PubMed ID: 21502699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urothelial carcinoma in situ: concerns about daily practice.
    Palou J; Rodriguez O; Gaya JM
    Eur Urol; 2015 May; 67(5):889-90. PubMed ID: 25576008
    [No Abstract]   [Full Text] [Related]  

  • 55. Intracavitary immunotherapy and chemotherapy for upper urinary tract cancer: current evidence.
    Carmignani L; Bianchi R; Cozzi G; Grasso A; Macchione N; Marenghi C; Melegari S; Rosso M; Tondelli E; Maggioni A
    Rev Urol; 2013; 15(4):145-53. PubMed ID: 24659911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re: antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
    Taneja SS
    J Urol; 2012 Feb; 187(2):471-2. PubMed ID: 22237316
    [No Abstract]   [Full Text] [Related]  

  • 57. [Long-term outcome of initial treatment with Bacillus Calmette-Guérin for carcinoma in situ of the upper urinary tract].
    Kita Y; Soda T; Mizuno K; Matsuoka T; Nakanishi S; Asai S; Taoka R; Inoue K; Terai A
    Hinyokika Kiyo; 2011 Jul; 57(7):353-7. PubMed ID: 21832868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
    Giannarini G; Kessler TM; Birkhäuser FD; Thalmann GN; Studer UE
    Eur Urol; 2011 Nov; 60(5):955-60. PubMed ID: 21807456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Anan G; Suyama T; Takeuchi N; Nakamura K; Sakamoto S; Nihei N; Ichikawa T
    Hinyokika Kiyo; 2013 May; 59(5):261-4. PubMed ID: 23719131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.